Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.06M Sell
5,483
-415
-7% -$72.4K 0.01% 939
2026
Q1
$1.01M Buy
5,898
+1,587
+37% +$310K 0.01% 874
2025
Q4
$972K Sell
4,311
-761
-15% -$166K 0.01% 825
2025
Q3
$963K Buy
5,072
+275
+6% +$50K 0.01% 847
2025
Q2
$756K Buy
4,797
+298
+7% +$44.9K 0.01% 854
2025
Q1
$793K Buy
4,499
+1,694
+60% +$329K 0.01% 816
2024
Q4
$551K Sell
2,805
-38
-1% -$8.01K 0.01% 890
2024
Q3
$674K Buy
2,843
+451
+19% +$106K 0.02% 788
2024
Q2
$506K Buy
2,392
+382
+19% +$86.8K 0.01% 873
2024
Q1
$508K Buy
2,010
+362
+22% +$84.5K 0.01% 818
2023
Q4
$381K Buy
1,648
+90
+6% +$18.5K 0.01% 899
2023
Q3
$307K Buy
+1,558
New +$338K 0.01% 886

Other funds holding IQV

Vident Advisory's IQV Position: Q2 2026 in Review

Vident Advisory reduced its IQVIA (IQV) stake by 7% in Q2 2026, selling an estimated $72.4K and leaving 5,483 shares worth $1.06M. The position accounts for 0.01% of the portfolio, ranked #939.

Vident Advisory first reported a position in IQV in Q3 2023 and has held it in 12 quarters since. 1,091 funds tracked by Wall St. Rank hold IQV as of Q2 2026.

  • Vident Advisory held 5,483 shares of IQVIA worth $1.06M as of Q2 2026.
  • Vident Advisory sold 415 IQVIA shares in Q2 2026, an estimated $72.4K.
  • IQVIA made up 0.01% of Vident Advisory's portfolio in Q2 2026, its #939 holding.
  • Vident Advisory first reported a position in IQVIA in Q3 2023 and has held it in 12 quarters since.
  • 1,091 funds tracked by Wall St. Rank held IQVIA as of Q2 2026.

Based on Vident Advisory's 13F filing for Q2 2026, filed 12 Aug 2026.